Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) Research & Development (2018 - 2025)

Historic Research & Development for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to $3.6 million.

  • Q32 Bio's Research & Development fell 7521.96% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.4 million, marking a year-over-year decrease of 4256.26%. This contributed to the annual value of $48.1 million for FY2024, which is 5173.19% up from last year.
  • As of Q3 2025, Q32 Bio's Research & Development stood at $3.6 million, which was down 7521.96% from $5.2 million recorded in Q2 2025.
  • Q32 Bio's 5-year Research & Development high stood at $27.1 million for Q4 2022, and its period low was $3.6 million during Q3 2025.
  • Its 5-year average for Research & Development is $15.1 million, with a median of $13.4 million in 2024.
  • In the last 5 years, Q32 Bio's Research & Development skyrocketed by 9222.83% in 2024 and then crashed by 7521.96% in 2025.
  • Over the past 5 years, Q32 Bio's Research & Development (Quarter) stood at $23.6 million in 2021, then rose by 14.81% to $27.1 million in 2022, then crashed by 69.28% to $8.3 million in 2023, then rose by 26.45% to $10.5 million in 2024, then plummeted by 66.29% to $3.6 million in 2025.
  • Its Research & Development was $3.6 million in Q3 2025, compared to $5.2 million in Q2 2025 and $7.1 million in Q1 2025.